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Background
Wild sea turtle populations are currently listed as threatened and endangered 
as a result of both natural and anthropogenic factors (Jones et al. 2016; 
Duffy et al. 2018; IUCN 2018). These include predation, disease, starvation, 
pollution, fisheries interaction and habitat degradation. Many natural threats 
including disease outbreaks have been exacerbated by human interaction 
(Dos Santos et al. 2010; Jones et al. 2016; Whilde et al. 2017). One disease of 
increasing threat to marine turtle populations worldwide is fibropapillomatosis 
(FP), a virulent cancer (Fig. 1), thought to be triggered by a chelonian-specific 
herpes virus, ChHV5 (Herbst et al. 1995; Jones et al. 2016; Work et al. 2017; 
Morrison et al. 2018).
First reported in the scientific literature in 1938, FP prevalence was as low 
as 1.5% in the Florida Keys at that time (Smith & Coates 1938). Eyewitness 
sources suggest the first cases occurred as early as the late 1800s (Cruz 
1985). Fibropapillomatosis did not reach epizootic proportions until the 
1980s when a combination of increased coastal development and human-
induced climate change began to significantly degrade juvenile sea turtle 
habitats. Presenting as single or several benign fibroepithelial cutaneous 
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lesions (Jones et al. 2016), the disease significantly affects turtle survivorship 
once the tumours are of significant size in locations inhibiting vision, feeding, 
internal organ function and locomotive ability. The disease progressed to 
a panzootic in the 1990s with outbreaks in the eastern Pacific, Hawaiian 
Islands, Indonesia and Australia (Duarte et al. 2012; Page-Karjian et al. 2014; 
Hargrove et al. 2016; Jones et al. 2016). Currently, there are a number of 
FP visual scoring systems including the fibropapillomatosis index (FPI) (Rossi 
et al. 2016) and a four-category size classification which ranks the tumour 
burden from 0 to 3 (Work & Balazs 1999).
 The number of turtles stranding with FP in Florida has exploded in recent 
years, with over 250 entering Florida rehabilitation facilities in 2017. This 
trend is likely to continue into the future (Foley 2015; Hargrove et al. 2016; 
Duffy et al. 2018). Reported in all seven marine turtle species, FP most 
severely impacts green sea turtles (Chelonia mydas). Evidence suggests that 
its geographic range is spreading to more northern latitudes where FP was 
never previously recorded. The disease is now undermining conservation 
efforts across the globe (Duarte et al. 2012; Page-Karjian et al. 2014; 
Hargrove et al. 2016; Jones et al. 2016; Duffy et al. 2018).
Currently, the only commonly applied treatment for FP is surgery, which 
is expensive, restricted to only a small number of turtle hospitals and 60% 
of the time results in tumour regrowth post-surgery (Page-Karjian et al. 
2014; Whilde et al. 2017). While the occurrence of FP tumours and post-
surgical regrowth has been recorded previously, the specific growth rates 
of tumours pre- and post-surgery have never been assessed in detail. Such 
data are vital for establishing a growth baseline to better understand the 
disease and factors that may be accelerating its growth. Additionally, tumour 
growth baselines are crucial when assessing the effectiveness of targeted 
therapeutics. Once baseline FP tumour growth rates are established, these 
can be used to compare the rate of tumour growth and regrowth in 
patients subjected to various candidate drug treatments in order to identify 
the most effective course of treatment for FP-afflicted patients. Innovative 
treatment approaches are vital to help maintain healthy marine populations 
until the chronic underlying causes of these diseases can be addressed and 
preventative measures can be enforced (Duffy et al. 2018).
Objectives
This paper documents the growth and post-surgical regrowth rates of FP 
tumours in four C. mydas patients at the University of Florida’s Whitney Sea 
Turtle Hospital. These data will indicate which tumour locations are more 
susceptible to accelerated tumour regrowth. The results will also be useful as 
baseline information for future drug treatment studies, as well as suggesting 
further beneficial refinements to tumour growth profiling techniques.
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Method
Sample population: This study used existing images, taken as part of the 
rehabilitative care of four juvenile C. mydas patients admitted to the Whitney 
Sea Turtle Hospital between September 2016 and April 2017. Images were 
taken using an Olympus Tough TG-4 approximately 30cm from each lesion, 
with a 25cm scale bar for accurate pixel comparison. All four patients were 
found stranded along the east coast of Florida between Anastasia State 
Park (north, 29.9083°N, 81.2837°W) and Ponce Inlet (south, 29.0779°N, 
80.9211°W), displaying fibropapilloma-like tumours. Each patient received 
medical care devised to best suit their particular circumstances; thus the 
number of surgeries and duration of tumour growth analysis varies for each 
turtle. The outcome of each patient differs, with some determined healthy 
enough for release and others requiring euthanasia and necropsy. Tumour 
removal surgeries involved the use of a CO2 laser to excise tumours and 
cauterize surgical incision sites.
Table 1. Carapace length, weight, origin, condition on arrival and FP tumour scores of green 
sea turtles (C. mydas) observed during this study at the Whitney Laboratory for Marine 















(Rossi et al. 
2016)
Chrystal 29.2 2.8 Volusia FL Normal body 
condition, FP
>66.5





Pons 42.8 7.5 Volusia FL Emaciated, FP >6.5
Remi 35.7 3.8 Volusia FL Emaciated, FP >205.6
Image analysis: ImageJ is an image processing programme designed for 
scientific multidimensional images (https://imagej.nih.gov/ij). Image analysis 
using this computer software allows accurate measurements of tumour two-
dimensional surface area. It should be noted that the surface measurements 
used in this study serve as a proxy for overall tumour growth. In future studies, 
physical measurements of the three-dimensional tumour structures will allow 
a more in-depth direct assessment of tumour growth dynamics. However, here 
we evaluated the use of ImageJ software to track tumour growth. Existing 
historical FP patient datasets primarily only contain visual records of tumour 
growth, so, if found to be an applicable approach, two-dimensional surface 
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Fig. 1. Location of designated FP tumour ‘clusters’ on green sea turtle anatomy  
(Patient 4: Remi).
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area measurement would then be retroactively applicable to a large cohort 
of patient data. Each tumour is assigned to a ‘cluster’ to enable analysis of 
tumour growth in designated locations on the turtle anatomy (Fig. 1 and 
Table 2). Each cluster was photographed by a member of the Whitney Sea 
Turtle Hospital veterinary team on arrival, at each check-up and after each 
surgery. These images were analysed in ImageJ in order to plot the growth 
(surface area) and post-surgical regrowth of each cluster.
Table 2. Body location and abbreviations of tumour clusters used in this study.
Location designated as tumour clusters Cluster abbreviation Figure 1 Cluster location 
number
Left Eye LEy 1
Right Eye REy 2
Dorsal Neck DNk 3
Ventral Neck VNk 4
Carapace Carapace 5
Plastron Plastron 6
Left Front Flipper Base LFFBa 7
Left Front Flipper Along LFFAl 8
Right Front Flipper Base RFFBa 9
Right Front Flipper Along RFFAl 10
Left Rear Flipper Base LRFBa 11
Left Rear Flipper Along LRFAl 12
Right Rear Flipper Base RRFBa 13
Right Rear Flipper Along RRFAl 14
Tail Tail 15
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Chrystal was first photographed at the Whitney Sea Turtle Hospital on January 
12th 2017 (Fig. 2A). She underwent three surgeries to mitigate the severity 
of her fibropapillomatosis burden. Photographs were taken after each of 
Chrystal’s surgeries on the following dates: 
 R February 8th: removal of tumours from Left Eye (LEy), Right Eye (REy), 
Right Rear Flipper Base (RRFBa) and Left Front Flipper Base (LFFBa).
 R May 1st: removal of tumours from Right Front Flipper Base (RFFBa) and 
Right Front Flipper Along (RRFAl). 
 R June 13th: removal of tumours from LEy and REy (for the second time) 
and Dorsal Neck (DNk).
The most persistent tumour regrowth was seen on Chrystal’s eyes (Fig. 2B 
& Table 3). Limited regrowth was seen on the RFFBa and RFFAl (Fig. 2B). 
No regrowth was seen on the LFFBa. All clusters left untreated by surgery 
showed continuous steady growth. Due to continual tumour regrowth and 
the diagnosis of internal lung tumours and impacts on quality of life, Chrystal 
was euthanised on August 9th 2017, after 210 days in rehab, with a thorough 
necropsy providing evidence of significant internal FP tumour growth – in 
particular, a large golf ball-sized tumour located within the shoulder of the 
RFFBa. The necropsy determined that Chrystal was a female. 
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Fig. 2. Fibropapillomatosis in a green turtle (Patient 1: Chrystal).  
(A) Chrystal’s initial intake photograph upon admittance to the hospital.  
(B) Growth profile of selected FP tumour clusters on Chrystal. 
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PATIENT 2: TAMATOA
Tamatoa was admitted to the Whitney Sea Turtle Hospital on April 17th 2017 
(Fig. 3A), after stranding at Anastasia State Park, Florida. 
 R Tamatoa underwent one surgery on May 15th 2017 to remove tumours 
from its RFFBa, LFFBa and RRFBa. 
Tamatoa showed no signs of tumour regrowth post-surgery (Fig. 3B & Table 3). 
Showing good health and no indication of regrowth, Tamatoa was released 
on July 13th 2017, after 88 days in rehab. Tamatoa was subsequently found 
re-stranded and alive on August 27th 2017 at Anastasia State Park as a result 
of being caught in a cast-net. There was no indication of FP tumours.
Fig. 3. Patient 2: Tamatoa. (A) Tamatoa’s initial intake photograph upon admittance to the 
hospital. Tamatoa was found stranded by the Salt Run fish cleaning table in Anastasia State 
Park, where he was habitually fed by local fishermen. (B) Growth profile of the surface area of 
Tamatoa’s RFFBa cluster, obstructed in (A) due to placement of flipper.
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PATIENT 3: PONS
Pons was reported as stranded to the Whitney Sea Turtle Hospital on September 
25th 2016 and was collected from the water at Ponce Inlet, Florida. Pons was 
first photographed at the Whitney Sea Turtle Hospital on October 4th 2016 
(Fig. 4A). Pons was thin, with a healed propeller wound to the first vertebral 
and left costal, and minimal algae and barnacles on the carapace. 
 R Pons underwent one surgery on December 14th 2017 to remove 
tumours from its LFFBa, RFFBa, LRFBa, RRFBa and Tail.
Pons showed the start of very minor regrowth on the LFFBa, RRFBa and Tail 
(Fig. 4B). No regrowth was seen on the RFFBa or LRFBa. Showing good health 
and no further regrowth, Pons was released on March 16th 2017, after 173 
days in rehab. Pons was subsequently caught and released by a fisherman on 
March 28th 2017; however, there was no indication of FP tumours, suggesting 
that the beginnings of regrowth regressed while in the wild.
Fig. 4. Patient 3: Pons.  
(A) Pon’s initial intake photograph upon admittance to the hospital. Found floating in Ponce 
Inlet, Volusia County, with monofilament tangled around the right rear flipper base.  
(B) Growth profile of selected FP tumour clusters on Pons. 
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Fig. 5. Patient 4: Remi. 
(A) Remi’s initial intake photograph upon admittance to the hospital. Remi was found 
and collected from the inshore waters of South Daytona Beach Canal off the Halifax River, 
underweight and lacking in energy. 
(B) Growth profile of selected FP tumour clusters on Remi. 
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PATIENT 4: REMI
Remi was reported as stranded to the Whitney Sea Turtle Hospital on April 10th 
2017 and was collected from the inshore waters of Halifax River, Florida. Remi was 
first photographed at the Whitney Sea Turtle Hospital on April 10th 2017 (Fig. 5A). 
Remi was thin and lethargic with mud and algae covering his carapace. The patient 
underwent four surgeries to mitigate the severity of its FP burden. Photographs 
were taken after each of Remi’s surgeries on the following dates in 2017: 
 R May 1st: removal of tumours from Carapace, RFFAl, RFFBa and Plastron. 
 R May 30th: removal of tumours from LEy. 
 R June 28th: removal of tumours from LFFAl, LFFBa, LRFBa and LRFAl. 
 R July 26th: removal of tumours from RRFBa, RRFAl, LEy (for the second time), 
Ventral Neck (VNk) and Plastron (for the second time). 
The most persistent tumour regrowth was seen on Remi’s left eye (LEy) as well as 
the Plastron (Fig. 5B). Minor regrowth was seen on the LFFBa (Fig. 5B). No regrowth 
was seen on the Carapace, VNk, RFFBa, RFFAl, LFFAl, LRFBa, LRFAl, RRFBa and 
RRFAl. Due to its multiple surgeries and continued regrowth Remi remained in the 
care of the Whitney Sea Turtle Hospital for a total of 344 days, but was successfully 
released on 20th March 2018.
Tumour growth rates by individual and cluster locations
We assessed the growth rates of all tumour clusters, examining whether there 
was any correlation in cluster location and the pre-surgery growth rate, across all 
four patients. Generally, plastron tumours and those at the base of the flippers 
tended to grow at a faster rate than other locations (Fig. 6A), although it should 
be noted that these clusters also tended to have the largest tumour burdens (Table 
3). Regrowth data were not available for some of Chrystal’s FP clusters, as surgery 
took place too soon after the first photograph to have a second image available 
(Table 3).
We next compared the predicted doubling time of each tumour (start size/pre-
surgery growth rate). Doubling time represents the hypothetical time it would 
take (in days) for a tumour to double its original size (size at commencement of 
measuring), assuming it continued to grow at its pre-surgery rate. While there 
was a slight trend for larger tumours to require a longer doubling time (Fig. 6B), 
despite their more rapid growth rate (Table 3), there was no strong correlation 
between the size of a tumour and its predicted doubling time (linear correlation, 
R2 = 0.01296).
In addition to characterising tumour growth rates as a baseline for future studies, 
we also investigated whether there was any prognostic value in the pre-surgery 
growth rates in terms of predicting patient outcome or the occurrence of post-
surgery tumour regrowth. However, the average tumour regrowth across all clusters 
of an individual turtle were not predictive of rehabilitation outcome (Fig. 6C).
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Fig. 6. Analysis of tumour growth rates.  
(A) Average pre-surgery tumour growth rates combined by cluster, across all four patients. 
(B) Predicted tumour doubling time by tumour starting size. Doubling time represents the 
hypothetical time it would take (in days) for a tumour to double its original size, assuming it 
had been allowed to continue to grow and maintained its pre-surgery growth rate.  
(C) Average pre-surgery tumour growth rates combined by individual patient, related to 
rehabilitation outcome.
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Next we examined whether any of the tumours’ growth characteristics 
(starting size, growth rate or growth rate/starting size) were predictive of the 
occurrence of post-surgery regrowth (Fig. 7A). Interestingly, for those tumour 
clusters with growth rate data available, the pre-surgery growth rate did not 
clearly indicate whether a tumour would regrow post-surgery (Fig. 7A, B). 
Fig. 7. Correlation of pre-surgery growth dynamics with the occurrence of post-surgical FP 
tumour regrowth. 
(A) Average pre-surgery tumour growth rates (left), tumour starting size (right) and growth 
rate/starting size (bottom), across all patients and clusters (for which regrowth information 
existed) grouped according to the occurrence of post-surgical tumour regrowth. Error bars 
denote standard error. 
(B) Tumour growth rate/starting size across patient clusters, grouped according to the 
occurrence of post-surgical tumour regrowth.
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Neither starting size (t-test, p = 0.6382, d.f. = 21), growth rate (t-test, p = 
0.7050, d.f. = 21) or growth rate/starting size (t-test, p = 0.3931, d.f. = 21) 
were significantly different between clusters exhibiting regrowth and those 
having no post-surgery regrowth. 
It should be noted that the negative growth rate for Chrystal’s REy cluster 
was as a result of initial inflammation in that tumour being reduced upon 
commencement of rehabilitative care. The reduction in size was not due to 
genuine natural tumour regression. This inflammation complication also tallies 
with the occurrence of post-surgical tumour regrowth in this eye. However, 
even if this cluster is excluded from the analysis there remains no significant 
difference between the no regrowth and regrowth clusters (t-test for growth 
rate p = 0.4925, d.f. = 20, t-test for rate/starting size, p = 0.9634, d.f. = 
20). Given this lack of significance we can rule out the use of these growth 
characteristics as prognostic markers of tumour regrowth. However, reassessing 
these features with a larger sample size would of course be highly desirable.
 
Discussion
Patients 2 and 3 received one surgery only as their symptoms were far less 
advanced than Patients 1 and 4. As their FP was less advanced, they showed 
minor or no regrowth and were released back into their wild populations. 
Coincidentally, both patients were caught alive and released by fishermen 
approximately one month later; however, there was no evidence of tumour 
regrowth. As the patients were tagged, the fishermen took photos prior to 
release to send to the hospital so as to keep track of patient health and 
location. 
Patients 1 and 4 displayed far more severe FP symptoms. Despite multiple 
rounds of surgery, persistent tumour regrowth was a recurring problem. 
The most susceptible sites requiring multiple surgeries were the eyes and 
the plastron. Therefore, these sites should receive special focus in any 
future adjunct post-surgery drug treatment trials. Due to the severity of 
their symptoms, Patient 1 required euthanasia and Patient 4 remained in 
rehabilitation almost one year after its initial stranding. Patient 1 displayed 
continuous tumour regrowth and poor health. Her necropsy subsequently 
showed extensive growth of internal FP tumours. 
The two smallest patients, Chrystal and Remi (Table 1), were those most 
affected by post-surgical tumour regrowth. Our observation supports the 
findings made by Page-Karjian et al. (2014) that smaller turtles (straight 
carapace lengths 30-35cm) were the most susceptible to FP tumour 
development while in rehabilitation. Page-Karjian et al. (2014) suggested that 
turtles are more likely to develop FP tumours during warmer rehabilitation 
months (April-September), an observation also postulated elsewhere (Cruz 
1985; Herbst et al. 1995; Jones et al. 2016; Duffy et al. 2018). This association 
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between warmer months and higher regrowth rates was also apparent with 
both Patients 1 and 4 in this study. The most commonly FP-afflicted body 
locations are stated to be the R/LFFBa, R/LFFAl, Tail, Plastron and R/LEy (Page-
Karjian et al. 2014). Again, the patients in this study support this finding. The 
presence of ocular tumours can be a good indication of the outcome of the 
Table 3. Pre-surgery fibropapillomatosis tumour growth characteristics and post-surgery 
regrowth rates.
Patient Cluster Start Size 
(mm2)
Growth Rate  












1. Chrystal Left Eye 460 7.0 0.016 Y 11
Right Eye 485 -17.0 -0.035 Y 11
Dorsal Neck 651 13.0 0.021 N 138
Ventral Neck 1476 18.0 0.012 N/A 209
Plastron 447 23.0 0.053 N/A 209
Left Front Base 3662 3.0 0.001 N 11
Left Front Along 202 15.0 0.076 N/A 209
Right Front Base 6234 94.0 0.015 Y 95
Right Front Along 564 10.0 0.019 Y 95
Left Rear Base 2111 48.0 0.023 N/A 209
Left Rear Along 43 1.0 0.024 N/A 209
Right Rear Base 7134 100.0 0.014 Y 11
Tail 185 15.0 0.081 N/A 209
2. Tamatoa Left Front Base 1232 12.0 0.010 N 14
Right Front Base 50 0.2 0.004 N 14
Right Rear Base 1806 81.0 0.045 N 14
3. Pons Left Front Base 341 3.0 0.010 Y 71
Right Front Base 616 5.0 0.010 N 71
Left Rear Base 1964 19.0 0.010 N 71
Right Rear Base 1143 13.0 0.012 Y 71
Tail 268 3.0 0.012 Y 71
4. Remi Left Eye 6 0.03 0.004 Y 35
Ventral Neck 78 0.6 0.007 N 88
Carapace 1981 N/A N/A N 21
Plastron 9903 N/A N/A Y 21
Left Front Base 561 4.0 0.007 Y 64
Left Front Along 421 8.0 0.021 N 64
Right Front Base 1282 N/A N/A N 21
Right Front Along 528 N/A N/A N 21
Left Rear Base 3738 48.0 0.013 N 64
Left Rear Along 1270 14.0 0.011 N 64
Right Rear Base 1316 9.0 0.008 N 88
 Right Rear Along 446 0.5 0.001 N 88
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patient, as turtles without FP lesions on the eye are eight times more likely to 
survive (Page-Karjian et al. 2014). The results from this study also support this 
suggestion, as those turtles without eye tumours were able to be released, 
while those with eye tumours required euthanasia or prolonged rehabilitation 
time and medical care. In previous studies, the number of tumour removal 
surgeries has not significantly related to patient outcome (Page-Karjian et 
al. 2014). However, in this study a greater number of surgeries did coincide 
with worse outcomes (euthanasia, extended rehabilitation time). In previous 
studies, 38.5% of turtles experienced post-surgical regrowth within an average 
of 36 days (Page-Karjian et al. 2014). In line with this, in our current study 
50% of turtles experienced FP regrowth within 40 days. Of the 33 tumour 
clusters surgically removed from these 4 patients, one third resulted in tumour 
regrowth. This is slightly less than the 60% tumour regrowth observed in 
previous studies (Page-Karjian et al. 2014).
The growth measurement protocol adopted in this study can be further 
improved for future research in order to increase its accuracy and the level 
of detailed analysis which is possible. Photos could be taken at a fixed 
distance and at a consistent angle for each tumour cluster, and physical 
measurements using callipers could be used to record accurate tumour 
dimensions. While providing more precise data, these physical methods, 
however, are considerably more time-consuming. Thus they are less likely to 
be broadly adopted across many rehabilitation facilities, which are generally 
time- and resource-limited.
Interestingly, this study suggests that the aggressiveness of the pre-surgery 
growth rates do not have a bearing on the occurrence of post-surgery 
tumour regrowth rates. Therefore, regrowth may be driven predominantly 
by other factors such as inherent genetic/viral features of each tumour, 
or tumour cells/tumour stem cells remaining in the body site post-surgery 
(deeper surgical margins may alleviate this, although these are not possible 
in some locations such as the eye). In line with the potential drivers of FP 
regrowth, we have recently shown that adjunct post-surgery treatment with 
the anti-cancer drug fluorouracil can help to dramatically reduce FP eye 
tumour regrowth (Duffy et al. 2018).
The analysis of tumour growth in these four patients provides a useful 
baseline with which to compare FP tumour growth rates in C. mydas 
given novel FP treatments. Future studies can compare this baseline with 
growth post-candidate drug treatment. Additionally, these data will provide 
useful baseline information for studies investigating the effect of potential 
environmental aggravators of FP tumour growth, such as UV exposure 
and pollutant exposure (Keller et al. 2014; Jones et al. 2016; Duffy et al. 
2018). If growth and regrowth rates can be reduced from the baseline rates 
indicated in this study, it could eliminate the need for multiple rounds of 
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surgery, consequently decreasing the stress on the patient and increasing 
their chances of successful re-introduction to their wild population. At a time 
when anthropogenic factors are accelerating disease emergence and species 
extinction (Whilde et al. 2017), it is vital to not only expand our scientific 
understanding of the mechanics of diseases such as fibropapillomatosis, 
but to use the knowledge gained to improve the care and recovery of 
endangered animal populations. 
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